(Q37215566)

19 August 2017

1 reference

title

Direct renin inhibition: an analysis of possible benefits (English)

1 reference

19 August 2017

Brian K Dockery

1

1 reference

19 August 2017

John D Bisognano

series ordinal

2

1 reference

19 August 2017

publication date

1 August 2008

1 reference

Current Hypertension Reports

19 August 2017

published in

1 reference

19 August 2017

volume

10

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

313-318

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-008-0058-2

19 August 2017

exact match

0 references

cites work

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1007%2FS11906-008-0058-2

Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-008-0058-2

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-008-0058-2

Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-008-0058-2

Structure of recombinant human renin, a target for cardiovascular-active drugs, at 2.5 A resolution

21 January 2018

1 reference

12 December 2020

Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial

1 reference

12 December 2020

Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors

1 reference

12 December 2020

Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension

1 reference

12 December 2020

Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms

1 reference

12 December 2020

Renal vascular responses to renin inhibition with zankiren in men*

1 reference

12 December 2020

Functional evidence for a role of vascular chymase in the production of angiotensin II in isolated human arteries

1 reference

12 December 2020

Clinical Pharmacokinetics and Efficacy of Renin Inhibitors

1 reference

12 December 2020

Aliskiren: a review of its use in the management of hypertension

1 reference

12 December 2020

Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats

1 reference

12 December 2020

Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.

1 reference

12 December 2020

Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren

1 reference

12 December 2020

Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists

1 reference

12 December 2020

Direct Renin inhibition with aliskiren in obese patients with arterial hypertension

1 reference

12 December 2020

Renal and endocrine responses to a renin inhibitor, enalkiren, in normal humans

1 reference

12 December 2020

The renin-angiotensin system: importance in physiology and pathology

1 reference

12 December 2020

Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications

1 reference

12 December 2020

Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients

1 reference

12 December 2020

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

1 reference

12 December 2020

Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril

1 reference

12 December 2020

Aldosterone in congestive heart failure

1 reference

12 December 2020

Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.

1 reference

12 December 2020

Rapid marked increase in plasma renin in rats treated with inhibitors of the renin system. Effects of 1-sar-8-ala-angiotensin II and of a synthetic converting enzyme inhibitor (nonapeptide, SQ 20.881) on normal and adrenalectomized rats

1 reference

12 December 2020

Renin inhibition in hypertension

1 reference

12 December 2020

Determinants of angiotensin II generation during converting enzyme inhibition

1 reference

12 December 2020

Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade

1 reference

12 December 2020

The difficult conception, birth and delivery of a renin inhibitor: controversies around aliskiren

1 reference

12 December 2020

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

1 reference

12 December 2020

Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure

1 reference

12 December 2020

The preparation, purification, and amino acid sequence of a polypeptide renin substrate

1 reference

12 December 2020

Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension

1 reference

12 December 2020

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

12 December 2020

Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin

1 reference

12 December 2020

Beneficial effects of combination of ACE inhibitor and angiotensin II type 1 receptor blocker on cardiac remodeling in rat myocardial infarction

1 reference

12 December 2020

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

1 reference

12 December 2020

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

1 reference

12 December 2020

Aliskiren, the first renin inhibitor for treating hypertension: reactive renin secretion may limit its effectiveness

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen

1 reference

12 December 2020

10.1007/S11906-008-0058-2

Identifiers

DOI

1 reference

19 August 2017

1 reference